AI Summary
✦ ClarthaPrice Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
Analyst coverage unavailable
Fundamentals
Fundamentals institutional score is 69 using growth durability 69.3.
Valuation
Valuation institutional score is 51 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
No usable analyst target or recommendation data was available.
Technical Structure
Technicals institutional score is 53 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is balanced or not decisive enough to tilt the tape. Based on 10 recent ticker-linked news items.
Signal Summary
Market intelligence remains Neutral. fundamentals provide support, while valuation and technical structure remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 10.3% below historical median. Valuation is declining — currently in the strongly undervalued zone (z-score: -0.6). Confidence: 83%.
Live forward EPS implies next-12-month EPS of ₹63.80. Applying the stock's normalized valuation corridor produces a fair range of ₹800.69 to ₹1,006.76, with base value near ₹900.86 (+25.4% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹63.80
Forward P/E
11.3x
Base Fair Value
₹900.86
Fair Range
₹800.69 - ₹1,006.76
Upside To Base
+25.4%
Estimate Source
Live forward EPS
Growth Estimate
+11.9%
5Y Average
10.83
Current
12.67
Overvalued
15.78
Undervalued
12.55
5Y Average
6.41
Current
7.59
Overvalued
8.61
Undervalued
3.38
5Y Average
1.42
Current
1.68
Overvalued
1.63
Undervalued
1.21
Peers & Comparison
Sector: Materials · Theme: Packaging
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
EPL LIMITED EPLPackaging | +17.7% | 8.2% | 18.9x Undervalued | -50% vs avg | -0.7% |
POLY MEDICURE LIMITED POLYMEDPackaging | +38.6% | 15.8% | 56.0x Premium | +49% vs avg | -14.2% |
AGI GREENPAC LIMITED trades at a discount (12.8x vs peer avg 37.5x), suggesting potential undervaluation relative to the Packaging cohort. Peers include EPL LIMITED, POLY MEDICURE LIMITED — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹785 CrJun 2026Latest net profit
₹100 CrJun 2026Latest EPS
₹15.39Jun 2026Net margin
22.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 558 | 615 | 623 | 622 | 566 | 599 | 658 | 705 | 688 | 602 | 634 | 742 | 785 |
| Expenses + | 427 | 481 | 472 | 477 | 430 | 445 | 489 | 551 | 546 | 452 | 483 | 589 | 610 |
| Operating Profit | 132 | 134 | 151 | 146 | 136 | 154 | 169 | 154 | 142 | 150 | 150 | 153 | 175 |
| OPM % | 24% | 22% | 24% | 23% | 24% | 26% | 26% | 22% | 21% | 25% | 24% | 21% | 22% |
| Other Income + | 8 | 5 | 3 | 10 | 10 | 12 | 16 | 37 | 34 | 5 | -1 | 53 | 9 |
| Interest | 18 | 23 | 21 | 25 | 20 | 23 | 20 | 21 | 17 | 11 | 11 | 9 | 10 |
| Depreciation | 37 | 41 | 42 | 42 | 42 | 47 | 44 | 44 | 41 | 43 | 44 | 44 | 45 |
| Profit before tax | 85 | 74 | 91 | 89 | 84 | 96 | 121 | 126 | 118 | 101 | 95 | 153 | 130 |
| Tax % | 26% | 25% | 26% | 28% | 25% | 25% | 25% | 23% | 25% | 25% | 24% | 24% | 23% |
| Net Profit + | 63 | 56 | 67 | 65 | 63 | 72 | 91 | 97 | 89 | 76 | 72 | 116 | 100 |
| EPS in Rs | 9.81 | 8.68 | 10.37 | 9.98 | 9.77 | 11.14 | 13.99 | 14.93 | 13.73 | 11.77 | 11.07 | 17.87 | 15.39 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Press Release / Media Release